Related Experiment Video
Updated: Jul 4, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials
Severine Loisel-Meyer1, Ronan Foley, Jeffrey A Medin
1Ontario Cancer Institute, University Health Network, 67 College Street, Toronto (ON) Canada M5G 2M1.
Abstract:
Immunotherapy against cancer basically aims at either broadly stimulating the immune system or at engineering an immune response against a targeted tumor associated antigen (TAA). In this review, we focus on the translation of immuno-gene therapy strategies into clinical trials for various cancers. Rather than being an exhaustive compendium of the literature, the focus of this article is to underline how anti-cancer immunotherapy strategies have evolved recently. Previously, studies have used different vectors to either express immuno-stimulatory molecules or a targeted TAA. Investigators are now directing efforts to both target a TAA and to stimulate the immune system by direct or viral administration of cytokines or co-stimulatory molecules. Some groups have also tried to combine genetic immunotherapy with chemotherapy, and results have been encouraging. This novel concept might open new perspectives for the treatment of patients with advanced-stage cancer.
Insights
Cancer immunotherapy is evolving, focusing on stimulating the immune system or targeting tumor antigens. Recent strategies combine targeting tumor antigens with immune stimulation, showing promise for advanced cancers.
Area of Science:
- Oncology
- Immunology
- Gene Therapy
Background:
- Cancer immunotherapy aims to stimulate the immune system or engineer responses against tumor-associated antigens (TAA).
- Recent advancements focus on translating immuno-gene therapy strategies into clinical applications for diverse cancers.
Purpose of the Study:
- To review the evolution of anti-cancer immunotherapy strategies.
- To highlight recent developments in immuno-gene therapy clinical trials.
Main Methods:
- Review of recent literature on immuno-gene therapy strategies.
- Focus on clinical trial translations and evolving therapeutic approaches.
Main Results:
- Shift from solely expressing immuno-stimulatory molecules or TAA to combined strategies.
- Integration of direct/viral cytokine or co-stimulatory molecule administration.
- Encouraging results from combining genetic immunotherapy with chemotherapy.
Conclusions:
- Current immuno-gene therapy strategies are evolving towards dual targeting and immune stimulation.
- Combination therapies, including genetic immunotherapy with chemotherapy, show potential for advanced cancers.
- These novel approaches may offer new treatment perspectives for patients with advanced-stage cancer.
More Related Videos
Related Concept Videos
Gene Therapy
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

